Current status and advances of fish vaccines in Malaysia.

Autor: Ridzuan MSM; Department of Marine Science, Kulliyyah of Science, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia.; National Fish Health Research Division, Fisheries Research Institute Batu Maung, Department of Fisheries Malaysia, 11960 Batu Maung, Penang, Malaysia., Abdullah A; National Fish Health Research Division, Fisheries Research Institute Batu Maung, Department of Fisheries Malaysia, 11960 Batu Maung, Penang, Malaysia., Ramly R; National Fish Health Research Division, Fisheries Research Institute Batu Maung, Department of Fisheries Malaysia, 11960 Batu Maung, Penang, Malaysia., Mansor NN; Department of Marine Science, Kulliyyah of Science, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia., Ramli N; Kulliyyah of Allied Health Science, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia., Firdaus-Nawi M; Department of Marine Science, Kulliyyah of Science, International Islamic University Malaysia, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia.; Laboratory of Aquatic Animal Health, Institute of Oceanography and Maritime Studies, International Islamic University Malaysia, Cherok Paloh, 26060 Kuantan, Pahang, Malaysia.
Jazyk: angličtina
Zdroj: Veterinary world [Vet World] 2022 Feb; Vol. 15 (2), pp. 465-482. Date of Electronic Publication: 2022 Feb 26.
DOI: 10.14202/vetworld.2022.465-482
Abstrakt: Fish diseases have a significant negative influence on the Malaysian aquaculture industry. Since the 1980s, the sector has grown in size, which has resulted in a rise in the prevalence of infectious outbreaks affecting both freshwater and marine cultured fish species. Demand for commercially available fish vaccinations is predicted to increase as infectious disease outbreaks continue to occur. In Malaysia, aquaculture vaccine research and development (R&D) are still in its infancy, with most efforts concentrating on producing vaccines against bacterial infections, most notably streptococcosis, vibriosis, and motile Aeromonas septicemia. Despite several attempts, no homegrown vaccine has been effectively introduced into the manufacturing pipeline to date. At the moment, only three imported aquatic vaccines have received full permission, a far cry from the 314 and 60 vaccines licensed in the poultry and porcine industries, respectively. This review will describe recent findings regarding the development of aquaculture vaccines for certain fish species and diseases in Malaysia. In our opinion, R&D on fish vaccines is critical to the aquaculture industry's viability.
Competing Interests: The authors declare that they have no competing interests.
(Copyright: © Ridzuan, et al.)
Databáze: MEDLINE